Navigation Links
Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product
Date:7/15/2009

out Cornerstone Therapeutics

Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets. The Company currently promotes multiple marketed products in the United States to respiratory-focused physicians and key retail pharmacies with its specialty sales force. The Company also has a late-stage clinical pipeline with four additional regulatory approval submissions targeted within the next three years. Key elements of the Company's strategy are to in-license or acquire rights to underpromoted, patent-protected, branded respiratory or related pharmaceutical products or late-stage product candidates; implement life cycle management strategies to maximize the potential value and competitive position of the Company's currently marketed products, newly acquired products and product candidates that are currently in development; grow product revenue through the Company's specialty sales force, which is focused on the respiratory and related markets; and maintain and strengthen the intellectual property position of the Company's currently marketed products, newly acquired products and product candidates.

Safe Harbor Statement

Statements in this press release regarding the progress and timing of our product development programs, including their related trials and regulatory approvals; our future opportunities; our strategy, future operations, financial position, future revenues and projected costs; our management's prospects, plans and objectives; and any other statements about management's future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Any statements that are not statements of hi
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cornerstone Therapeutics Joins the Russell 3000(R) Index
2. Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Issuance and Sale of Stock
3. TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform
4. Cornerstone Therapeutics Announces Management Change
5. Cornerstone Therapeutics Reports First Quarter 2009 Financial Results
6. Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA
7. Cornerstone Therapeutics to Host First Quarter 2009 Conference Call
8. OnCore(r) 9.0 Released: 'Top 5' Priorities and Collaborative Initiatives Cornerstones of Product Development
9. Cornerstone Therapeutics Announces New Board of Directors
10. Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
11. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... The cost of diabetes care in the United States ... more than $322 billion annually, a new report shows. ... prediabetes care, which have risen 74 percent, and undiagnosed ... In 2012, excess medical costs and lost productivity ... American. That total includes $244 billion in medical costs ...
(Date:11/21/2014)... 2014 Richard Wolfe, co-founder and ... present advanced benefits administration strategies during the Game ... Leadership Summit. This Game Changer breakout session enables ... present cutting-edge solutions and best practices to top ... real-time data exchange between health and welfare benefits ...
(Date:11/21/2014)... Kansas City, Mo (PRWEB) November 21, 2014 ... has received the Get With The Guidelines®–Heart Failure ... improvement measures outlined by the American Heart Association/American ... guidelines for heart failure patients. , Get With ... that helps hospital teams provide the most up-to-date, ...
(Date:11/21/2014)... NJ (PRWEB) November 21, 2014 The ... homemade, high calorie dishes, plenty of gravy and a ... could be the best time of year to begin ... Diet Doc has uncovered the secret to losing unhealthy, ... the fattening holiday recipes. , The insight to Diet ...
(Date:11/21/2014)... Midway through the research period for the 2015 ... of Health Plans, preliminary data shows volatility in the ... is a comprehensive resource with enrollment data and contact ... 2015 edition will be available in February. ... Division, the company’s exclusive in-house research team, have identified ...
Breaking Medicine News(10 mins):Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 2Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 3Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 4Health News:Data from Atlantic Information Services’s Forthcoming Directory Shows Volatility in U.S. Health Care Market 2
... , McALLEN, Texas, Dec. 3 The Ensign ... it has acquired three Texas skilled nursing facilities: the ... the 100-bed Alta Vista Rehabilitation & Healthcare in Brownsville; ... The acquisitions were effective December 1, 2009. , (Logo: ...
... , MINNEAPOLIS, Dec. 3 The American Association of Poison ... Minneapolis, Minnesota as an accredited poison control center - a ... AAPCC places the Hennepin Regional Poison Center among 58 accredited ... major accomplishment. It means we have met the national standards ...
... , NEW YORK, Dec. ... is available in its catalogue: , Point of Care ... review and analysis of the point of care (POC) diagnostics ... POC diagnostics industry , Covers federal regulation of POC ...
... , Statement by John Gay, Executive Director and ... to a new campaign launched today by the U.S. ... marketplace of "rogue" marketers selling steroids as dietary supplements, ... association representing retailers and manufacturers of dietary supplements and ...
... finds rising incidence of obesity could counter recent increases in ... health of the U.S. population has improved over the past ... but a new study suggests those gains might soon be ... level off or drop. , If current trends in both ...
... added batches now available, many more to come, NIH director ... stem cell lines have been added to the pool that ... lines will soon be made available, U.S. health officials announced ... lines approved for research funded by the U.S. National Institutes ...
Cached Medicine News:Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 2Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 3Health News:Hennepin Regional Poison Center Designated as an Accredited Poison Control Center 2Health News:Reportlinker Adds Point of Care Diagnostics 2Health News:Reportlinker Adds Point of Care Diagnostics 3Health News:Reportlinker Adds Point of Care Diagnostics 4Health News:Reportlinker Adds Point of Care Diagnostics 5Health News:Reportlinker Adds Point of Care Diagnostics 6Health News:Reportlinker Adds Point of Care Diagnostics 7Health News:Reportlinker Adds Point of Care Diagnostics 8Health News:Reportlinker Adds Point of Care Diagnostics 9Health News:Reportlinker Adds Point of Care Diagnostics 10Health News:Reportlinker Adds Point of Care Diagnostics 11Health News:Reportlinker Adds Point of Care Diagnostics 12Health News:Natural Products Association Issues Statement on New Supplement Safety Campaign 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 2Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 3
(Date:11/21/2014)... --  Wellcentive , the industry leader in end-to-end ... today being named one of the four finalists ...  Sponsored by Intel, the world leader in computing ... companies developing leading-edge technology and unique approaches to ... Wellcentive,s Mason Beard , senior vice ...
(Date:11/18/2014)... Nov. 18, 2014 Respiratory Motion and IMI ... medical device and services providers in Japan ... Respiratory Motion,s innovative respiratory depression monitor, the ExSpiron™. As ... are working together to connect the clinical community in ... history of bringing innovative medical devices and new technology ...
(Date:11/18/2014)... 18, 2014 Investor-Edge has initiated coverage ... ), Geron Corporation (NASDAQ: GERN ), Tekmira Pharmaceuticals ... GALE ), and XOMA Corporation (NASDAQ: ... accessed at: http://investor-edge.com/register . The US markets ... as the Dow Jones Industrial Average finished at 17,647.75, up ...
Breaking Medicine Technology:Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 2Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 3Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 5
... Stereotaxis, Inc. (NASDAQ: STXS ) today reported financial ... Third Quarter 2011 Financial Results Revenue ... the year ago period.  The decrease was primarily due to ... for a more efficient solution for complex ablation procedures and ...
... Nov. 7, 2011 Alexza Pharmaceuticals, Inc. (Nasdaq: ... fiscal quarter ended September 30, 2011 and provided a ... September 30, 2011 and 2010, as reported in accordance ... (GAAP), were $13.4 million and $0.6 million, respectively.  The ...
Cached Medicine Technology:Stereotaxis Reports Third Quarter Financial Results 2Stereotaxis Reports Third Quarter Financial Results 3Stereotaxis Reports Third Quarter Financial Results 4Stereotaxis Reports Third Quarter Financial Results 5Stereotaxis Reports Third Quarter Financial Results 6Stereotaxis Reports Third Quarter Financial Results 7Stereotaxis Reports Third Quarter Financial Results 8Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 2Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 3Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 4Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 5Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 6Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 7
Large: 22 x 25 mm, 0.9 x 1.0 inches. With holes. For support of the orbital rim following enucleation. Available in methylmethacrylate....
Designed to insert eye spheres using spring loaded plunger. Polished finish. Overall length: 125 mm, 4.9 inches....
... Size: 3.0 x 7.5 x 80 ... Sponge II line designed by Harvey ... is a closed cell sponge which ... soft with rounded edges to minimize ...
... mm. Storz offers the original Scleral ... A. Lincoff, M.D. The material is ... non-toxic and non-antigenic. Implants are soft ... intrusion. These implants are packaged sterile ...
Medicine Products: